Abstract: Methods of determining whether specific drugs or patients carry an increased risk of causing or developing, respectively, long QT syndrome or Torsades de Pointes and methods of treating such patients.
Type:
Grant
Filed:
January 7, 2021
Date of Patent:
November 7, 2023
Assignee:
TABULA RASA HEALTHCARE, INC.
Inventors:
Jacques Turgeon, Lauren E. Steffen, Gabriel Badea, Veronique Michaud
Abstract: Embodiments of the invention relate to a system and method for population-based medication risk stratification and for generating a personalized medication risk score. The system and method may pertain to a software that relates pharmacological characteristics of medications and patient's drug regimen data into algorithms that (1) enable identification and/or prognosis of high-risk patients for adverse drug events within a population distribution, and (2) allow computation of a personalized medication risk score which provides personalized, evidence-based information for safer drug use to mitigate medication risks.
Type:
Application
Filed:
June 10, 2022
Publication date:
January 19, 2023
Applicant:
TABULA RASA HEALTHCARE, INC.
Inventors:
Jacques TURGEON, Veronique MICHAUD, Brian CICALI
Abstract: Embodiments of the invention relate to a system and method for population-based medication risk stratification and for generating a personalized medication risk score. The system and method may pertain to a software that relates pharmacological characteristics of medications and patient's drug regimen data into algorithms that (1) enable identification and/or prognosis of high-risk patients for adverse drug events within a population distribution, and (2) allow computation of a personalized medication risk score which provides personalized, evidence-based information for safer drug use to mitigate medication risks.
Type:
Grant
Filed:
May 8, 2020
Date of Patent:
June 14, 2022
Assignee:
TABULA RASA HEALTHCARE, INC.
Inventors:
Jacques Turgeon, Veronique Michaud, Brian Cicali
Abstract: Methods of determining whether specific drugs or patients carry an increased risk of causing or developing, respectively, long QT syndrome or Torsades de Pointes and methods of treating such patients.
Type:
Application
Filed:
January 7, 2021
Publication date:
May 13, 2021
Applicant:
TABULA RASA HEALTHCARE, INC.
Inventors:
Jacques TURGEON, Lauren E. STEFFEN, Gabriel BADEA, Veronique MICHAUD
Abstract: Methods of determining whether specific drugs or patients carry an increased risk of causing or developing, respectively, long QT syndrome or Torsades de Pointes and methods of treating such patients.
Type:
Grant
Filed:
May 19, 2017
Date of Patent:
January 12, 2021
Assignee:
TABULA RASA HEALTHCARE, INC.
Inventors:
Jacques Turgeon, Lauren E. Steffen, Gabriel Badea, Veronique Michaud
Abstract: Embodiments of the invention relate to a system and method for population-based medication risk stratification and for generating a personalized medication risk score. The system and method may pertain to a software that relates pharmacological characteristics of medications and patient's drug regimen data into algorithms that (1) enable identification and/or prognosis of high-risk patients for adverse drug events within a population distribution, and (2) allow computation of a personalized medication risk score which provides personalized, evidence-based information for safer drug use to mitigate medication risks.
Type:
Application
Filed:
May 8, 2020
Publication date:
October 1, 2020
Applicant:
TABULA RASA HEALTHCARE, INC.
Inventors:
Jacques TURGEON, Veronique MICHAUD, Brian CICALI
Abstract: A medication risk mitigation method utilizing three interventions: a prospective intervention performed by a prescriber, a concurrent intervention performed by a pharmacist and a retroactive intervention performed by a pharmacist. At each intervention, the system of the instant invention utilizes a computer program to compare each prescribed medication to a series of intrinsic and extrinsic data sources in order to identify potential contraindications and, if necessary, modify a prescription. The system also permits secure messaging between prescribers and pharmacists, each with access to the computer program, so as to facilitate communication and reduce medication risks. The system of this invention also permits modeling for hypothetical medication modifications based on the same intrinsic and extrinsic data sources.
Abstract: Methods of determining whether specific drugs or patients carry an increased risk of causing or developing, respectively, long QT syndrome or Torsades de Pointes and methods of treating such patients.
Type:
Application
Filed:
May 19, 2017
Publication date:
September 26, 2019
Applicant:
TABULA RASA HEALTHCARE, INC.
Inventors:
Jacques TURGEON, Lauren J. STEFFEN, Gabriel BADEA